BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3040% above fair value

$72.80−0.02 (-0.03%)

Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne statistics

105 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q1 FY2027, expected soon
Last ex-dividend date: Nov 13, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $11.43B; $282.97M
Enterprise Value: $11.28B; $154.96M
PE Ratio: 66.79; 25.08
PS Ratio: 9.31; 3.71
PB Ratio: 5.28; 2.17
P/TBV Ratio: 12.61; 2.39
P/FCF Ratio: 37.10; 19.12
P/OCF Ratio: 33.87; 13.10

Enterprise valuationIndustry

EV / Sales: 9.19; 2.66
EV / EBITDA: 33.42; 16.59
EV / EBIT: 46.85; 19.03
EV / FCF: 36.61; 22.15

Share statisticsIndustry

Shares Outstanding: 157M; 58M
Shares Change (YoY): -0.52%; 10.9%
Shares Change (QoQ): 0.61%; 0.51%
Float: 156M; 49M
Shares Held by Insiders: 0.36%; 11.6%
Shares Held by Institutions: 111.6%; 56.4%

Short sellingIndustry

Short Interest: 8M; –
Short Interest Change: 2.00%; -0.76%
Short % of Float: 4.92%; 9.06%
Short % of Shares Outstanding: 4.91%; 6.38%
Days to Cover: 2.73; 5.16

Stock price statisticsIndustry

52-Week High: $72.88; –
52-Week Low: $43.20; –
20-Day Moving Average: $72.66; –
50-Day Moving Average: $72.52; –
200-Day Moving Average: $63.30; –
Average True Range (14): $0.13; –
Price Change (1 Week): 0.10%; -0.50%
Price Change (1 Month): 0.44%; -0.33%
Price Change (3 Months): 0.87%; -17.2%
Price Change (6 Months): 62.2%; -20.1%
Price Change (YTD): 23.8%; -20.1%
Price Change (1 Year): 26.7%; -19.3%
Price Change (3 Years): 26.6%; -23.4%
Price Change (5 Years): -42.3%; -76.4%
Price Change (10 Years): 173.5%; -62.4%
Average Volume (10 Days): 3M; –
Average Volume (20 Days): 3M; –
Average Volume (90 Days): 3M; –
Relative Volume: 0.84; 0.73
Relative Strength Index (14): 61.1; 47.6
Volatility (1 Year): 42.9%; 80.2%
Beta (5 Years): 1.07; 1.07

MarginsIndustry

Gross Margin: 65.8%; 53.1%
Operating Margin: 19.6%; -37.1%
Pretax Margin: 18.5%; -12.1%
EBITDA Margin: 27.5%; -25.0%
FCF Margin: 25.1%; -9.55%

Returns on capitalIndustry

Return on Invested Capital (ROIC): 8.81%; -34.0%
Return on Capital Employed (ROCE): 10.6%; -37.7%

Financial positionIndustry

Current Ratio: 2.28; 3.30
Quick Ratio: 1.53; 2.37
Debt / Equity: 0.09; 0.49
Debt / EBITDA: 0.59; 3.15
Debt / FCF: 0.65; 4.62
Net Debt / EBITDA: -0.44; 1.97
Interest Coverage: 27.16; -6.27

GrowthIndustry

Revenue Growth (YoY): 0.94%; 6.82%
EPS Growth (YoY): 122.4%; -12.8%
FCF Growth (YoY): 37.6%; 6.85%
Revenue Growth (3Y CAGR): 2.25%; 2.25%
Revenue Growth (5Y CAGR): 5.47%; 6.41%
EPS Growth (3Y CAGR): -13.0%; -0.17%
EPS Growth (5Y CAGR): 5.92%; 3.77%

EfficiencyIndustry

Asset Turnover: 0.48; 0.40
Inventory Turnover: 2.10; 2.68
Revenue Per Employee: $409.40K; $426.63K
Employee Count: 3,000; 75
WACC: 10.1%; 10.1%

Income statement (TTM)Industry

Revenue: $1.23B; $66.56M
Gross Profit: $807.58M; $111.43M
Operating Income: $240.84M; -$20.20M
Pretax Income: $227.38M; -$13.50M
EBITDA: $337.58M; -$16.36M
EPS (Diluted): $1.09; -$0.77

Balance sheetIndustry

Cash & Short-Term Investments: $350.04M; $65.30M
Total Debt: $200.00M; $118.49M
Net Cash (Debt): $150.04M; $16.31M
Net Cash Per Share: $0.96; $0.70
Equity (Book Value): $2.17B; $53.12M
Book Value Per Share: $13.79; $1.49
Tangible Book Value: $906.58M; $26.11M
Working Capital: $463.56M; $77.59M

Cash flow (TTM)Industry

Operating Cash Flow: $337.60M; -$12.07M
Capital Expenditures: -$29.40M; -$939.00K
Free Cash Flow: $308.20M; -$18.37M
FCF Per Share: $1.96; -$0.42

Dividends and yieldsIndustry

FCF Yield: 2.70%; -8.81%
Dividend Yield: 0.44%; 1.86%
Shareholder Yield: 0.44%; 0.00%
Dividend Per Share: $0.32; $0.83
Dividend Growth (YoY): 0.00%; 2.37%
Years of Dividend Growth: 0; 0
FCF Payout Ratio: 16.2%; 44.4%

Taxes and interestIndustry

Interest Expense: $8.87M; $2.98M
Income Tax: $55.41M; $79.50K
Effective Tax Rate: 24.4%; 20.7%

Scores and fair valueIndustry

Graham Number: $18.39; $19.42
Graham Upside: -74.7%; -45.8%
Altman Z-Score: 16.15; 0.28
Beneish M-Score: -2.52; -2.62
Lynch Fair Value: $6.46; –
Lynch Upside: -91.1%; -27.9%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	TECH	S&P 500	Difference	TECH per year	S&P 500 per year
1 month	+0.5%	-2.4%	+2.9 pts
3 months	+1.0%	-1.2%	+2.2 pts
Year to date	+24.3%	+12.3%	+12.0 pts
1 year	+23.7%	+12.4%	+11.3 pts
3 years	+28.5%	+78.8%	−50.4 pts	+8.7%	+21.4%
5 years	-41.2%	+75.2%	−116.4 pts	-10.1%	+11.9%
10 years	+189.2%	+311.1%	−121.9 pts	+11.2%	+15.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

8M TECH shares were sold short on Oct 30, 2026, up 2.0% from the previous report, or 4.92% of the shares available to trade. At recent volumes it would take 2.7 days to buy them back. Over the last 20 sessions, 38.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	7,703,626	+2.0%	2,824,318	2.7
Oct 15, 2026	7,552,208	+2.3%	2,624,542	2.9
Sep 30, 2026	7,385,034	+11.4%	3,556,189	2.1
Sep 15, 2026	6,627,623	+12.5%	2,492,188	2.7
Aug 31, 2026	5,889,876	-8.9%	2,359,300	2.5
Aug 14, 2026	6,463,327	-30.3%	2,850,913	2.3
Jul 31, 2026	9,277,342	-23.5%	3,964,369	2.3
Jul 15, 2026	12,123,448	-23.8%	5,339,634	2.3
Jun 30, 2026	15,915,631	-12.6%	10,806,094	1.5
Jun 15, 2026	18,204,307	+31.5%	2,955,086	6.2
May 29, 2026	13,846,089	-4.9%	2,788,250	5.0
May 15, 2026	14,553,011	+9.1%	3,959,564	3.7